Medidata’s Julie Iskow Named a “Luminary” by the Healthcare Businesswomen’s Association
May 11 2017 - 8:30AM
Business Wire
Medidata (NASDAQ:MDSO), the leading global provider of
cloud-based technology and data analytics for clinical research, is
pleased to announce that Julie Iskow has been named a 2017
“Luminary” by the Healthcare Businesswomen’s Association (HBA). She
will be recognized at the HBA’s 28th Woman of the Year (WOTY)
event, held Thursday, May 11, in New York City.
As EVP and chief technology officer, Julie is responsible for
the vision and direction of Medidata’s platform and solutions
strategy. She leads the part of the organization that designs,
develops, delivers and supports the Company’s client-facing
products, technology infrastructure and enterprise
applications—providing the architecture to help Medidata’s
customers and partners accelerate hope for patients on a global
scale.
“Julie is the definition of a leader, collaborating closely with
her team to help solve some of healthcare’s biggest challenges,”
said Mike Capone, Medidata’s chief operating officer. “She is
commended for her technological insight, which is enabling the
collective life sciences ecosystem to make better decisions from a
business, R&D and health outcomes perspective. We’re thrilled
that the HBA has recognized her relentless focus on developing and
delivering innovation that is transforming clinical development
and, ultimately, improving people’s lives.”
Drawing upwards of 2,000 individuals from across the life
sciences industry, the May 11th WOTY luncheon celebrates this
year’s HBA Luminaries and Rising Stars. The honorees represent
professionals in various disciplines and healthcare
sectors—including pharmaceutical, biotechnology, advertising,
public relations, medical education, scientific discovery, clinical
development and market research—who serve as role models in their
organizations, actively mentoring others and helping to advance the
global healthcare space.
The HBA will also honor this year’s Woman of the Year Bahija
Jallal, PhD, executive vice president, AstraZeneca, and head of
MedImmune; 2017 Honorable Mentor Joaquin Duato, worldwide chairman,
pharmaceuticals, Johnson & Johnson; and 2017 STAR (Strategic
Transformation Achievement Recognition) Ceci Zak, principal and COO
at Batten & Co (a strategic consulting firm within the Omnicom
Group).
Connect with Medidata:
- Read our blog, Geeks Talk Clinical
- Tweet this: .@Medidata chief #tech
officer @JulieIskow named a 2017 Luminary by @HBAnet
http://ow.ly/UTRz30bBSho #hbaimpact #lifesciences
- Follow us on Twitter: @Medidata
- Find us on LinkedIn
About the HBA
The Healthcare Businesswomen’s Association (HBA) is a global
not-for-profit organization dedicated to furthering the advancement
and impact of women in healthcare worldwide. With 15 chapters
throughout the US and in Europe, HBA serves a community of over
30,000 individuals and 100 Corporate Partners. The HBA provides
networking forums to build relationships; knowledge sharing and
access to thought leaders to broaden perspective; educational
programs to develop leadership skills and cutting edge industry
knowledge and recognition of outstanding women and companies to
promote visibility of their achievements. For more information,
visit http://www.hbanet.org.
About Medidata
Medidata is reinventing global drug and medical device
development by creating the industry's leading cloud-based
solutions for clinical research. Through our advanced applications
and intelligent data analytics, Medidata helps advance the
scientific goals of life sciences customers worldwide, including
over 850 global pharmaceutical companies, biotech, diagnostic and
device firms, leading academic medical centers, and contract
research organizations.
The Medidata Clinical Cloud® brings a new level of quality and
efficiency to clinical trials that empower our customers to make
more informed decisions earlier and faster. Our unparalleled
clinical trial data assets provide deep insights that pave the way
for future growth. The Medidata Clinical Cloud is the primary
technology solution powering clinical trials for 18 of the world's
top 25 global pharmaceutical companies and is used by 16 of the top
20 medical device developers—from study design and planning through
execution, management and reporting.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170511005253/en/
Medidata SolutionsInvestors:Anthony D’Amico, +1
732-767-4331adamico@mdsol.comorMedia:Erik Snider, +1
646-362-2997esnider@mdsol.com
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Apr 2023 to Apr 2024